The heterogeneity of idiopathic pulmonary fibrosis (IPF) limits its diagnosis and treatment.
The association between the pathophysiological features and the serum protein signatures …

In this study, we leveraged a combination of single cell RNAseq, cytometry by time of flight
(CyTOF), and flow cytometry to study the biology of a unique macrophage population in …

Rationale: CXC motif chemokine 13 (CXCL13) mediates B-cell trafficking and is increased,
proportionately to disease activity, in many antibody-mediated syndromes. Dysregulated B …

Idiopathic pulmonary fibrosis (IPF) is a chronic progressive interstitial lung disease
characterized by damage to the alveolar epithelium, leading to fibrosis and excessive …

The extremely high mortality of both lung cancer and Idiopathic pulmonary fibrosis (IPF) is a
global threat. Early detection and diagnosis can reduce their mortality. Since fibrosis is a …

Molecular biology studies show that RNA N6-methyladenosine (m6A) modifications may
take part in the incidence and development of idiopathic pulmonary fibrosis (IPF) …

Scleroderma-associated pulmonary fibrosis (SSc-PF) and idiopathic pulmonary fibrosis (IPF)
are two of many chronic fibroproliferative diseases that are responsible for nearly 45% of all …

Idiopathic pulmonary fibrosis (IPF) remains a lethal disease with unknown etiology and
unmet medical need. The aim of this study was to perform an integrative analysis of multiple …

Idiopathic pulmonary fibrosis (IPF) is an interstitial lung disease characterized by chronic
progressive pulmonary fibrosis and a poor prognosis. Genetic studies, including …

Idiopathic pulmonary fibrosis (IPF) is a progressive disease with unremitting extracellular
matrix deposition, leading to a distortion of pulmonary architecture and impaired gas …